Overview
Lobbying Costs
200,000€ - 299,999€
Financial year: Feb 2022 - Jan 2023
Lobbyists (Full time equivalent)
3.5 Fte (7)
Lobbyists with EP accreditation
2
High-level Commission meetings
35
Lobbying Costs over the years
-
Info
Association of the European Self-Care Industry (AESGP)
EU Transparency Register
99565011637-64 First registered on 04 May 2009
Goals / Remit
AESGP represents the manufacturers of non-prescription medicines, food supplements and self-care medical devices in Europe.
Because staying healthy as a society starts with each of us, our mission at AESGP is to support everyone’s access to safe, effective and sustainable self-care in Europe, empowering people to take better care of their own and their families’ health
The key objectives of AESGP are:
1. Proactively shape the regulatory, legislative, political and economic framework at European level where the self-care industry operates, with an exclusive focus on non-prescription medicines, self-care medical devices and food supplements.
2. Advocate for the individual, societal and economic value and benefits of self-care with a particular focus on self-care products in Europe.Main EU files targeted
Activities in the areas of pharmaceuticals / food supplements / medical devices legislation and regulation and public health and environmental policy.
Address
Head Office
Avenue de Tervuren, 7
Brussels B-1040
BELGIUMEU Office
Avenue de Tervuren, 7
Brussels B-1040
BELGIUMWebsite
-
People
Total lobbyists declared
7
Employment time Lobbyists 100% 1 75% 2 25% 4 Lobbyists (Full time equivalent)
3.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 17 Sep 2024
Name Start date End Date Jurate SVARCAITE 24 Jan 2024 23 Jan 2025 Luis RHODES BAIAO 17 Oct 2023 16 Oct 2024 Jurate SVARCAITE 25 Jan 2023 24 Jan 2024 Luis RHODES BAIAO 13 Oct 2022 13 Oct 2023 Luis RHODES BAIAO 12 Oct 2021 12 Oct 2022 Maud PERRUDIN 10 Jan 2020 09 Jan 2021 Luis RHODES BAIAO 05 Nov 2019 31 Oct 2020 Jurate SVARCAITE 06 Jul 2019 04 Jul 2020 Ms Andrada Armasu 10 Jul 2015 08 Jul 2016 Hubertus CRANZ 02 Jul 2015 29 Jun 2016 Kinga ADAMASZWILI 05 Nov 2014 03 Nov 2015 Ms Miranda Moussa 22 Oct 2014 20 Oct 2015 Hubertus CRANZ 17 May 2014 05 Jun 2015 Ms Miranda Moussa 25 Oct 2013 24 Oct 2014 Kinga ADAMASZWILI 16 Oct 2013 15 Oct 2014 Hubertus CRANZ 24 May 2013 17 May 2014 Mr Georgios Yiangou 11 Apr 2013 10 Apr 2014 Hubertus CRANZ 22 Mar 2013 21 Jun 2013 Kinga ADAMASZWILI 23 Jan 2013 16 Oct 2013 Ms Miranda Moussa 07 Nov 2012 25 Oct 2013 Mr Georgios Yiangou 02 Oct 2012 11 Apr 2013 Hubertus CRANZ 09 Feb 2012 01 Mar 2013 Mr Luca BATTISTINI 09 Feb 2012 19 Nov 2012 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
AESGP represents its members in the Global Self-Care Federation (GSCF), which represents the views of the self-care industry globally and enjoys non-governmental status with the World Health Organization.
AESGP is in contact with all relevant organisations in its area of activity.Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Feb 2022 - Jan 2023
Lobbying costs for closed financial year
200,000€ - 299,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
200,000€ - 299,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
Working Group on Plant Health#E03832/2#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=103432 #MEMBER #C#Industry#SMEs10 - International Matters#X03565/11#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100607 #OBSERVER #C#Industry#SMEs08 - EUDAMED#X03565/13#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100886 #OBSERVER #C#Industry#SMEsMedical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3565 #OBSERVER #C#Industry#SMEs07 - New Technologies#X03565/9#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100604 #OBSERVER #C#Industry#SMEs12 - Nomenclature#X03565/1#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100117 #OBSERVER #C#Industry#SMEsConsultation Forum on Access and benefit sharing (ABS)#E03396#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3396 #MEMBER #C#Industry#SMEsAdvisory Group on Sustainability of Food Systems#E03832#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3832 #MEMBER #C#Industry#SMEs13 - Annex XVI #X03565/2#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100252 #OBSERVER #C#Industry#SMEs06 - Borderline and Classification (B&C)#X03565/8#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100603 #OBSERVER #C#Industry#SMEs09 - Unique Device Identification (UDI)#X03565/10#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100606 #OBSERVER #C#Industry#SMEsZero Pollution Stakeholder Platform#E03790#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3790 #MEMBER #C#Industry03 - Clinical Investigation and Evaluation (CIE)#X03565/5#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100600 #OBSERVER #C#Industry#SMEs02 - Standards#X03565/4#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100599 #OBSERVER #C#Industry#SMEsAnimal Health Advisory Committee#E03832/1#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=103292 #MEMBER #C#Industry#SMEs04 - Post-Market Surveillance and Vigilance (PMSV)#X03565/6#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100601 #OBSERVER #C#Industry#SMEsWorking Group on Seeds and Propagating Material#E03832/3#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=103433 #MEMBER #C#Industry#SMEs
Groups (European Parliament)
Climate change, biodiversity and sustainable development,Competitive European Industry: long-term and sustainable investment,Green new deal
Communication activities
Organisation of Annual Meetings and of conferences covering topics of interest for AESGP members.
Publications on topics relevant for the association.
Further details available at: www.aesgp.euOther activities
None declared
Meetings
Meetings
35 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 24 May 2022 Location Brussels - virtual meeting Subject Exchange of views on the upcoming reform of the pharmaceutical legislation Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
-
Date 09 Sep 2021 Location Brussels - Webex Subject Presentation of the work of AESGP and perspectives from the self care industry on the pharmaceutical strategy. DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 07 Jun 2021 Location Brussels Subject VTC meeting - Access to Medicines Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 Apr 2021 Location online Subject Health Union Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Catherine Sustek (Cabinet member)
Other Lobbyists -
Date 06 Nov 2020 Location Brussels - virtual Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 30 Sep 2020 Location Online Subject Call with pharmaceutical and medical device supply Chain on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Karolina Herbout-Borczak (Cabinet member)
- Giorgios Rossides (Cabinet member)
Other Lobbyists -
Date 29 Jun 2020 Location Online Subject Call with pharmaceutical and medical device industry associations on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 29 Jun 2020 Location Brussels Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 15 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 17 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 03 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 03 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 27 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 27 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 13 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Sep 2019 Location Brussels Subject introduction of AESGPand activities, namely in the area of pharmaceuticals, food supplements; public health issues such as AMR; sustainability of health systems DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 15 Jun 2018 Location Brussels, Berl Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists -
Date 24 Nov 2016 Location Brussels Subject digitisation in the medical sector DG Günther Oettinger Attending - Markus Schulte (Cabinet member)
-
Date 17 Nov 2016 Location Brussels Subject Roundtable on the future of the General Food Law Regulation Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Nathalie Chaze (Cabinet member)
- Marco Valletta (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists -
Date 17 Mar 2016 Location Brussels Subject Health Claims legislation Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Nathalie Chaze (Cabinet member)
-
Date 03 Feb 2016 Location Brussels Subject Discussion on self-medecine Industry DG Health and Food Safety Attending - Xavier Prats Monné (Director-General)
-
Date 03 Feb 2016 Location Brussels Subject Discussion on the non-prescription medicines DG Health and Food Safety Attending - Xavier Prats Monné (Director-General)
-
Date 16 Jul 2015 Location Brussels, Belgium Subject Botanicals Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Arunas Vinciunas (Cabinet member)
-
Date 09 Jan 2015 Location Brussels, Belgium Subject Introductory meeting to discuss the Self-Medication Industry Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)